design, synthesis and biological evaluations of novel oxindoles as hiv-1 non-nucleoside reverse...

1
2006 Indole derivatives R 0140 Design, Synthesis and Biological Evaluations of Novel Oxindoles as HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors. Part 1. — Compound (VIa) shows the highest antiviral effects of all products tested. Derivative (VIb) exhibits high antiviral activity whereas the bulkier analogue (VIc) is completely inactive. These re- sults show that the cyclopropane region is sensitive to small perturbation. — (JIANG, T.; KUHEN, K. L.; WOLFF, K.; YIN, H.; BIEZA, K.; CALDWELL, J.; BURSULAYA, B.; WU, T. Y.-H.; HE*, Y.; Bioorg. Med. Chem. Lett. 16 (2006) 8, 2105-2108; Genomics Inst., Novartis Res. Found., San Diego, CA 92121, USA; Eng.) — C. Oppel 29- 096

Upload: tao-jiang

Post on 11-Jun-2016

226 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Design, Synthesis and Biological Evaluations of Novel Oxindoles as HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors. Part 1

2006

Indole derivativesR 0140 Design, Synthesis and Biological Evaluations of Novel Oxindoles as HIV-1

Non-Nucleoside Reverse Transcriptase Inhibitors. Part 1. — Compound (VIa) shows the highest antiviral effects of all products tested. Derivative (VIb) exhibits high antiviral activity whereas the bulkier analogue (VIc) is completely inactive. These re-sults show that the cyclopropane region is sensitive to small perturbation. — (JIANG, T.; KUHEN, K. L.; WOLFF, K.; YIN, H.; BIEZA, K.; CALDWELL, J.; BURSULAYA, B.; WU, T. Y.-H.; HE*, Y.; Bioorg. Med. Chem. Lett. 16 (2006) 8, 2105-2108; Genomics Inst., Novartis Res. Found., San Diego, CA 92121, USA; Eng.) — C. Oppel

29- 096